Vanguard Global Advisers’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.3K Buy
+366
New +$7.32K ﹤0.01% 3550

Other funds holding ADRX

Vanguard Global Advisers's ADRX Position: Q3 2026 in Review

Vanguard Global Advisers opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 366 shares worth $7.3K. The stake represents ﹤0.01% of the portfolio and ranks #3550 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Vanguard Global Advisers held 366 shares of ADARx Pharmaceuticals worth $7.3K as of Q3 2026.
  • ADARx Pharmaceuticals was a new Vanguard Global Advisers position in Q3 2026.
  • ADARx Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3550 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.